CCL4 and melanoma: This discrepancy may be due in part to decreased secretion of chemokine CCL4 by melanoma cells arising from active β-catenin signaling, resulting in hampered CD103+ DC tumor infiltration and impeded CD103+ DC chemotaxis (106).